The Supreme Court’s 6-3 ruling is expected to have a minimal impact on drug approvals and other scientific determinations, but matters steeped in the interpretation of regulation and statute, such as marketing exclusivity, could face a heightened risk of challenge, legal experts say.

The House Appropriations Agriculture, Rural Development, and FDA Subcommittee advanced the FDA’s fiscal year 2025 funding bill, beginning a likely long and difficult budget cycle. 

EFSA-commissioned report proposes changes to the way the authority conducts consultations on its scientific assessments which could give industry more opportunities for involvement.

The House Appropriations Agriculture, Rural Development, and FDA Subcommittee advanced the FDA’s fiscal year 2025 funding bill, beginning a likely long and difficult budget cycle. 

Finished product following Reagan-Udall food safety programs review establishes Human Foods Program in commissioner’s office while also realigning centers, offices and divisions across agency to improve collaboration with regulatory affairs, which conducts facility inspections and other field operations.

Senate committee amends bill to lower to $250 the largest civil penalty for violations; exempt retail clerks from “disciplinary action or discharge by the retail establishment” related to violations; and make changes to state’s Health and Safety Code effective in January 2026.

Doctor's Best acquires Viactiv calcium and magnesium brand from Guardion; VitaliyNow is Society Brands’ third 2024 acquisition; and VitaminLab formulation services on CharmHealth.

Consumer health manufacturer Uriach has agreed to acquire Germany's Pascoe Naturmedizin and through a separate transaction France's Laboratoires Ineldéa, following investment by private-equity firm ICG.

CV Sciences closes purchase of Elevated Softgels, a manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. Captek Softgel starts gummy supplement production at a 60,000-square foot facility.

Coca Gauff mixes Naked smoothies; Caitlan Clake, Jayson Tatum Have Gatorade’s “IT”; Mike Tyson punches for LF*GO! Pouches; and USANA provides nutrition for Jamaican bobsledders.

Supreme Court ruling on Purdue bankruptcy should “derail any attempt by J&J to return the talc litigation to the bankruptcy courts,” says class action plaintiff’s attorney. A federal court, Justice Gorsuch states, relieved Purdue owners of liability “without securing the consent of those affected or placing anything approaching their total assets on the table.”

Doctor's Best acquires Viactiv calcium and magnesium brand from Guardion; VitaliyNow is Society Brands’ third 2024 acquisition; and VitaminLab formulation services on CharmHealth.

Alliance Pharma has been hit by a non-cash impairment charge of £46.4m related to its Amberen dietary supplement reflecting the brand's struggles in the US e-commerce market.

Strong sales in Germany and Italy helped drive up PharmaSGP's consumer health product revenues by around a quarter in the opening three months of 2024.

Headwinds for the Russian ruble and Turkish lira held back growth at Recordati's OTC business in the first quarter of 2024.

The Supreme Court’s 6-3 ruling is expected to have a minimal impact on drug approvals and other scientific determinations, but matters steeped in the interpretation of regulation and statute, such as marketing exclusivity, could face a heightened risk of challenge, legal experts say.

Whether called “dark patterns,” “shady” online marketing practices, or simply deception on the internet, the issue has taken on high importance at the US Federal Trade Commission and is being tackled by new laws in a growing number of states. Amin Talati Wasserman partner Lauren Aronson discusses in this interview with HBW Insight.

BBB National Programs found FTC’s proposed Trade Regulation Rule on the Use of Consumer Reviews and Testimonials largely effective with some certainty on whether product reviews or customer testimonials are violations of its false advertising standards. But it =expects some clarifications may come in final rule.

Doctor's Best acquires Viactiv calcium and magnesium brand from Guardion; VitaliyNow is Society Brands’ third 2024 acquisition; and VitaminLab formulation services on CharmHealth.

Germany's Stada has its eyes on expansion in the US dietary supplements market with the launch of histamine intolerance line Histasolv.

Perrigo’s adjusted operating income from formula business in 2023 was around half the $140m it expects. Level won’t be reached in 2024 but it’s “well on track to recapturing” that amount in 2025 and to “capturing all of that plus in 2026,” says CEO Patrick Lockwood-Taylor.

Coca Gauff mixes Naked smoothies; Caitlan Clake, Jayson Tatum Have Gatorade’s “IT”; Mike Tyson punches for LF*GO! Pouches; and USANA provides nutrition for Jamaican bobsledders.

The BBB National Programs, Inc.’s Children’s Advertising Review Unit reminds advertisers its Advertising and Privacy Guidelines extend to the use of AI in ads for children and points them to its recent warning that it will ‘strictly enforce’ those guidelines.

During recent investor conference, president Stephan Gratziani and CFO John DeSimone discuss Herbalife’s restructuring in addition to progress on digital transformation program and lack of progress on expectations for marketing to consumers prescribed GLP-1 drugs for weight loss.

Bayer Consumer Health and its effervescent vitamin brand Berocca were subjects of denigratory remarks by an online competitor in a recent UK advertising complaint ruling. The ASA’s Freddie Alcock talks HBW Insight through the complaint, explaining in this exclusive interview why denigration is never a good look for advertisers.

“So lacking in substance that it ‘stands out’ from the dozens of [patent infringement] challenges I have encountered as a judge in the last five years,” says Colm Connolly, Delaware district chief judge. His ruling doesn’t end the firms’ litigation as related cases continue in federal courts in California and New York.

“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.